These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 28115842

  • 1. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
    Dilektasli AG, Demirdogen Cetinoglu E, Uzaslan E, Budak F, Coskun F, Ursavas A, Ercan I, Ege E.
    Int J Chron Obstruct Pulmon Dis; 2017; 12():199-208. PubMed ID: 28115842
    [Abstract] [Full Text] [Related]

  • 2. Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD.
    Capozzolo A, Carratù P, Dragonieri S, Falcone VA, Quaranta VN, Liotino V, D'Alba G, Castellana G, Resta O.
    Respir Care; 2017 May; 62(5):572-578. PubMed ID: 28270543
    [Abstract] [Full Text] [Related]

  • 3. The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype.
    Miłkowska-Dymanowska J, Białas AJ, Szewczyk K, Kurmanowska Z, Górski P, Piotrowski WJ.
    Int J Chron Obstruct Pulmon Dis; 2018 May; 13():3879-3884. PubMed ID: 30568439
    [Abstract] [Full Text] [Related]

  • 4. Association between serum CCL-18 and IL-23 concentrations and disease progression of chronic obstructive pulmonary disease.
    Rong B, Fu T, Rong C, Liu W, Li K, Liu H.
    Sci Rep; 2020 Oct 20; 10(1):17756. PubMed ID: 33082377
    [Abstract] [Full Text] [Related]

  • 5. Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease.
    Sin DD, Miller BE, Duvoix A, Man SF, Zhang X, Silverman EK, Connett JE, Anthonisen NA, Wise RA, Tashkin D, Celli BR, Edwards LD, Locantore N, Macnee W, Tal-Singer R, Lomas DA, ECLIPSE Investigators.
    Am J Respir Crit Care Med; 2011 May 01; 183(9):1187-92. PubMed ID: 21216880
    [Abstract] [Full Text] [Related]

  • 6. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J, Díaz O, Repetto PB, Morales A, Saldías F, Lisboa C.
    Int J Chron Obstruct Pulmon Dis; 2015 May 01; 10():525-33. PubMed ID: 25792820
    [Abstract] [Full Text] [Related]

  • 7. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
    Tomioka R, Kawayama T, Suetomo M, Kinoshita T, Tokunaga Y, Imaoka H, Matsunaga K, Okamoto M, Hoshino T.
    Int J Chron Obstruct Pulmon Dis; 2016 May 01; 11():207-16. PubMed ID: 26893552
    [Abstract] [Full Text] [Related]

  • 8. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
    Reilev M, Lykkegaard J, Halling A, Vestbo J, Søndergaard J, Pottegård A.
    NPJ Prim Care Respir Med; 2017 Apr 17; 27(1):25. PubMed ID: 28416794
    [Abstract] [Full Text] [Related]

  • 9. Is serum iron responsive protein-2 level associated with pulmonary functions and frequent exacerbator phenotype in COPD?
    Acet Öztürk NA, Görek Dilektaşlı A, Demirdöğen E, Coşkun F, Ursavaş A, Karadağ M, Kunt Uzaslan E.
    Tuberk Toraks; 2020 Sep 17; 68(3):252-259. PubMed ID: 33295723
    [Abstract] [Full Text] [Related]

  • 10. Stability of Frequent Exacerbator Phenotype in Patients with Chronic Obstructive Pulmonary Disease.
    Krachunov I, Kyuchukov N, Ivanova Z, Yanev NA, Hristova PA, Pavlov P, Glogovska P, Popova T, Ivanov YY.
    Folia Med (Plovdiv); 2018 Dec 01; 60(4):536-545. PubMed ID: 31188775
    [Abstract] [Full Text] [Related]

  • 11. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
    Fu JJ, McDonald VM, Baines KJ, Gibson PG.
    Chest; 2015 Sep 01; 148(3):618-629. PubMed ID: 25950204
    [Abstract] [Full Text] [Related]

  • 12. Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
    Santibáñez M, Garrastazu R, Ruiz-Nuñez M, Helguera JM, Arenal S, Bonnardeux C, León C, García-Rivero JL.
    PLoS One; 2016 Sep 01; 11(6):e0158727. PubMed ID: 27362765
    [Abstract] [Full Text] [Related]

  • 13. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M, García-Sidro P, Fernández-Nistal A, Buendía MJ, Espinosa de Los Monteros MJ, Esquinas C, Molina J.
    Int J Chron Obstruct Pulmon Dis; 2015 Sep 01; 10():2571-9. PubMed ID: 26664105
    [Abstract] [Full Text] [Related]

  • 14. The association of tidal EFL with exercise performance, exacerbations, and death in COPD.
    Aarli BB, Calverley PM, Jensen RL, Dellacà R, Eagan TM, Bakke PS, Hardie JA.
    Int J Chron Obstruct Pulmon Dis; 2017 Sep 01; 12():2179-2188. PubMed ID: 28794622
    [Abstract] [Full Text] [Related]

  • 15. Physical activity and the frequency of acute exacerbations in patients with chronic obstructive pulmonary disease.
    Schönmann M, Sievi NA, Clarenbach CF, Brack T, Brutsche M, Frey M, Irani S, Leuppi JD, Ruediger J, Senn O, Thurnheer R, Kohler M.
    Lung; 2015 Feb 01; 193(1):63-70. PubMed ID: 25503750
    [Abstract] [Full Text] [Related]

  • 16. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG.
    JAMA; 2013 Jun 12; 309(22):2353-61. PubMed ID: 23757083
    [Abstract] [Full Text] [Related]

  • 17. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.
    Lin CM, Yang TM, Yang YH, Tsai YH, Lee CP, Chen PC, Chen WC, Hsieh MJ.
    Int J Chron Obstruct Pulmon Dis; 2020 Jun 12; 15():289-299. PubMed ID: 32103928
    [Abstract] [Full Text] [Related]

  • 18. Serum periostin in patients hospitalized for COPD exacerbations.
    Konstantelou E, Papaioannou AI, Loukides S, Bartziokas K, Papaporfyriou A, Papatheodorou G, Bakakos P, Papiris S, Koulouris N, Kostikas K.
    Cytokine; 2017 May 12; 93():51-56. PubMed ID: 28511944
    [Abstract] [Full Text] [Related]

  • 19. COPD Exacerbator Phenotype is Inversely Associated with Current Smoking But Not with Haptoglobin Phenotype.
    Tal S, Adir Y, Stein N, Shalom H, Lache O, Levy A, Shteinberg M.
    Isr Med Assoc J; 2019 Jan 12; 21(1):19-23. PubMed ID: 30685900
    [Abstract] [Full Text] [Related]

  • 20. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.
    McGarvey L, Lee AJ, Roberts J, Gruffydd-Jones K, McKnight E, Haughney J.
    Respir Med; 2015 Feb 12; 109(2):228-37. PubMed ID: 25613107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.